Celgene (CELG) PT Lowered to $112 at Evercore ISI, Keeps 'Outperform'
Tweet Send to a Friend
Evercore ISI analyst Umer Raffat lowered his price target on Celgene (NASDAQ: CELG) to $112.00 (from $155.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
